4//SEC Filing
Schwartz Jeffrey Lawrence 4
Accession 0000899243-23-009117
CIK 0001773427other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 5:00 PM ET
Size
5.8 KB
Accession
0000899243-23-009117
Insider Transaction Report
Form 4
Schwartz Jeffrey Lawrence
Director10% Owner
Transactions
- Sale
Common Stock
2023-03-16$28.50/sh−1,750,000$49,875,000→ 3,081,307 total(indirect: See footnote)
Holdings
- 5,924
Common Stock
Footnotes (1)
- [F1]Consists of shares of common stock held directly by BC SW, LP. Bain Capital Life Sciences Investors, LLC ("BCLSI") is the general partner of BC SW, LP. Mr. Schwartz is a Partner of BCLSI. As a result, Mr. Schwartz may be deemed to share voting and dispositive power with respect to the shares of common stock held by BC SW, LP. Mr. Schwartz disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Documents
Issuer
SpringWorks Therapeutics, Inc.
CIK 0001773427
Entity typeother
Related Parties
1- filerCIK 0001702957
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 5:00 PM ET
- Size
- 5.8 KB